News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
741,412 Results
Type
Article (54411)
Company Profile (666)
Press Release (686335)
Section
Business (211032)
Career Advice (3385)
Deals (37443)
Drug Delivery (120)
Drug Development (85010)
Employer Resources (185)
FDA (17053)
Job Trends (16242)
News (360637)
Policy (34652)
Tag
2024 BioCapital Digital (20)
2024 BioForest Digital (16)
2024 BioForest Standard (1)
2024 BioMidwest Digital (14)
2024 BioMidwest Standard (2)
2024 Bio NC Digital (19)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (20)
2024 Biotech Beach Digital (15)
2024 Biotech Beach Standard (9)
2024 Genetown Digital (10)
2024 Genetown Standard (12)
2024 Lone Star Bio Digital (17)
2024 Pharm Country Digital (13)
2024 Pharm Country Standard (7)
2025 BioForest Digital (8)
2025 Lone Star Bio Digital (11)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (2)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (2)
2026 Genetown Elite (3)
2026 Pharm Country Elite (1)
2026 Pharm Country Premier (1)
2026 Pharm Country Standard (1)
Academia (2800)
Academic (1)
Accelerated approval (3)
Adcomms (29)
Allergies (86)
Alliances (51710)
ALS (90)
Alzheimer's disease (1446)
Antibody-drug conjugate (ADC) (136)
Approvals (17019)
Artificial intelligence (256)
Autoimmune disease (19)
Automation (13)
Bankruptcy (387)
Best Places to Work (12291)
BIOSECURE Act (21)
Biosimilars (109)
Biotechnology (460)
Bladder cancer (63)
Brain cancer (28)
Breast cancer (264)
Cancer (2102)
Cardiovascular disease (174)
Career advice (2855)
Career pathing (33)
CAR-T (160)
Cell therapy (447)
Cervical cancer (19)
Clinical research (68534)
Collaboration (827)
Compensation (453)
Complete response letters (30)
COVID-19 (2777)
CRISPR (42)
C-suite (223)
Cystic fibrosis (104)
Data (1958)
Decentralized trials (2)
Denatured (26)
Depression (47)
Diabetes (268)
Diagnostics (6740)
Digital health (18)
Diversity (6)
Diversity, equity & inclusion (45)
Drug discovery (121)
Drug pricing (116)
Drug shortages (32)
Duchenne muscular dystrophy (91)
Earnings (85413)
Editorial (39)
Employer branding (24)
Employer resources (158)
Events (121706)
Executive appointments (663)
FDA (18178)
Featured Employer (64)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (732)
Gene editing (108)
Generative AI (24)
Gene therapy (319)
GLP-1 (799)
Government (4709)
Grass and pollen (4)
Guidances (47)
Healthcare (19910)
Huntington's disease (22)
IgA nephropathy (25)
Immunology and inflammation (126)
Indications (27)
Infectious disease (2915)
Inflammatory bowel disease (146)
Inflation Reduction Act (11)
Influenza (47)
Intellectual property (86)
Interviews (663)
IPO (17421)
IRA (49)
Job creations (4459)
Job search strategy (2340)
Kidney cancer (9)
Labor market (35)
Layoffs (524)
Leadership (20)
Legal (8322)
Liver cancer (76)
Lung cancer (309)
Lymphoma (132)
Machine learning (2)
Management (62)
Manufacturing (300)
MASH (67)
Medical device (14283)
Medtech (14288)
Mergers & acquisitions (20499)
Metabolic disorders (709)
Multiple sclerosis (75)
NASH (23)
Neurodegenerative disease (98)
Neuropsychiatric disorders (31)
Neuroscience (1960)
NextGen: Class of 2025 (7261)
Non-profit (4570)
Northern California (2451)
Now hiring (38)
Obesity (388)
Opinion (268)
Ovarian cancer (74)
Pain (86)
Pancreatic cancer (78)
Parkinson's disease (139)
Partnered (21)
Patents (212)
Patient recruitment (96)
Peanut (51)
People (60716)
Pharmaceutical (133)
Pharmacy benefit managers (21)
Phase I (21431)
Phase II (30204)
Phase III (22664)
Pipeline (1017)
Podcasts (93)
Policy (130)
Postmarket research (2548)
Preclinical (9104)
Press Release (68)
Prostate cancer (96)
Psychedelics (38)
Radiopharmaceuticals (267)
Rare diseases (396)
Real estate (6526)
Recruiting (73)
Regulatory (23708)
Reports (41)
Research institute (2507)
Resumes & cover letters (537)
Rett syndrome (3)
RNA editing (3)
RSV (44)
Schizophrenia (73)
Series A (132)
Series B (83)
Service/supplier (26)
Sickle cell disease (55)
Southern California (2127)
Special edition (18)
Spinal muscular atrophy (158)
Sponsored (33)
Startups (4043)
State (2)
Stomach cancer (16)
Supply chain (66)
The Weekly (65)
United States (22126)
Vaccines (748)
Venture capitalists (39)
Webinars (13)
Weight loss (279)
Women's health (32)
Worklife (18)
Date
Today (117)
Last 7 days (644)
Last 30 days (2653)
Last 365 days (35840)
2025 (8255)
2024 (37574)
2023 (42213)
2022 (53450)
2021 (58021)
2020 (56456)
2019 (49411)
2018 (37590)
2017 (35519)
2016 (35450)
2015 (41184)
2014 (34208)
2013 (28898)
2012 (30632)
2011 (31019)
2010 (28618)
Location
Africa (982)
Alabama (55)
Alaska (7)
Arizona (204)
Arkansas (14)
Asia (44222)
Australia (7451)
California (5708)
Canada (1893)
China (501)
Colorado (259)
Connecticut (279)
Delaware (132)
Europe (98999)
Florida (829)
Georgia (200)
Hawaii (1)
Idaho (60)
Illinois (552)
India (26)
Indiana (312)
Iowa (10)
Japan (143)
Kansas (103)
Kentucky (25)
Louisiana (10)
Maine (64)
Maryland (848)
Massachusetts (4429)
Michigan (230)
Minnesota (390)
Mississippi (2)
Missouri (84)
Montana (31)
Nebraska (25)
Nevada (56)
New Hampshire (67)
New Jersey (1633)
New Mexico (31)
New York (1630)
North Carolina (1052)
North Dakota (7)
Northern California (2451)
Ohio (200)
Oklahoma (15)
Oregon (45)
Pennsylvania (1274)
Puerto Rico (10)
Rhode Island (29)
South America (1364)
South Carolina (17)
South Dakota (1)
Southern California (2127)
Tennessee (92)
Texas (859)
Utah (171)
Virginia (144)
Washington D.C. (63)
Washington State (551)
West Virginia (3)
Wisconsin (57)
741,412 Results for "basf the chemical company".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
PURE Bioscience Announces a New Distribution Agreement With Hydrite Chemical Company
January 21, 2025
·
6 min read
Press Releases
Amaran Biotech Signs MOU with Nippon Fine Chemical
March 7, 2025
·
3 min read
Press Releases
Key Brain Chemical Can “Pause” Pregnancy After Conception
March 6, 2025
·
5 min read
Press Releases
Nucleus Biologics Launches NB-KUL™ DF: A DMSO-Free, Chemically-Defined Cryomedia Revolutionizing Cell and Gene Therapy Cryopreservation
October 15, 2024
·
3 min read
Business
Montai Therapeutics Appoints Renowned Chemical Innovator Larry Hamann to Company’s Board of Directors, Convenes Multidisciplinary Scientific Advisory Board to Inform Strategic Momentum
Montai Therapeutics is expanding its network of renowned scientific and technical advisors with the appointment of Larry Hamann to its Board of Directors and the launch of the company’s Scientific Advisory Board (SAB).
May 29, 2024
·
6 min read
Opinion
Companies Vie to Develop a Hunter Syndrome Therapy That Reaches the Brain
Several companies—including JCR Pharmaceuticals, Denali Therapeutics and Regenxbio—have products in the pipeline that could improve treatment options for this rare disease.
February 3, 2025
·
3 min read
·
Jia Jie Chen
Press Releases
Protagonist Therapeutics Named to Fast Company’s Annual List of the World’s Most Innovative Companies of 2025
March 19, 2025
·
6 min read
Press Releases
GE HealthCare to Acquire Remaining 50% Stake in Nihon Medi-Physics (NMP), a Leading Radiopharmaceutical Company in Japan, from Sumitomo Chemical
December 2, 2024
·
6 min read
Biotech Bay
Nurix Presents the Discovery and Chemical Structure of First-in-Class CBL-B Inhibitor NX-1607 at the American Chemical Society (ACS) Meeting
Nurix Therapeutics, Inc. (Nasdaq: NRIX) today disclosed the discovery and structure of NX-1607 in the First Time Disclosures session at the American Chemical Society Spring 2024 meeting in New Orleans, LA.
March 20, 2024
·
6 min read
Press Releases
Aadi Bioscience Relaunches as Whitehawk Therapeutics Marking Evolution into ADC Company
March 18, 2025
·
10 min read
1 of 74,142
Next
